Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema

This prospective, open-label, single-arm, non-randomized clinical trial, assessed the efficacy of a 2-year treat-and-extend (T&E) regimen involving intravitreal aflibercept injection (IAI), with the longest treatment interval set to 16 weeks, and adjunct focal/grid laser in diabetic macula edema...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Takao, Toriyama, Yuichi, Takamura, Yoshihiro, Sugimoto, Masahiko, Nagaoka, Taiji, Sugiura, Yoshimi, Okamoto, Fumiki, Saito, Michiyuki, Noda, Kousuke, Yoshida, Shigeo, Ishibazawa, Akihiro, Sawada, Osamu, Murata, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904904/
https://www.ncbi.nlm.nih.gov/pubmed/33627712
http://dx.doi.org/10.1038/s41598-021-83811-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904904/
https://www.ncbi.nlm.nih.gov/pubmed/33627712
http://dx.doi.org/10.1038/s41598-021-83811-y

Ejemplares similares